# MEDCOM

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/medcom

- Industry: Healthcare IT
- Headquarters: Tokyo, Japan
- Website: www.medcom.ne.jp/
- Total disclosed funding: $20M
- Latest round: Series C (Jul 4, 2023)
- Investors on record: 9

## About

Established in 2016 and based in Tokyo, Japan, MEDCOM, INC., formerly known as Frontier Field, Inc., offers specialized smartphones for medical institutions designed to enhance communication and integration with electronic medical records (EMR). In March 2024, Frontier Field, Inc. raised amount in venture funding from Terumo.

The firm’s smartphones include features like direct calling functions and secure healthcare communications, advancing digital healthcare through their ICT platform, contributing to digital transformation and operational improvements in healthcare settings. The company offers advanced communication technologies as a replacement to traditional PHS, fax, and paper-based communications. 

The company intends to use the March 2024 funds to expand its market reach.

## Funding rounds

- Series C, Jul 4, 2023, $14M — SBI Investment, Yamanashi Chugin Management Consulting, SUZUKEN CO., LTD., NCB Venture Capital, Otsuka Pharmaceutical Factory, Inc.
- Series B, Jun 8, 2022, $6M — University of Tokyo Edge Capital Partners, ITOCHU Techno-Solutions, Global Catalyst Partners, Alfresa Corporation

## Investors

- University of Tokyo Edge Capital Partners (https://capitalatlas.ai/funds/university-of-tokyo-edge-capital-partners) — Series B
- ITOCHU Techno-Solutions — Series B
- Global Catalyst Partners (https://capitalatlas.ai/funds/global-catalyst-partners) — Series B
- Alfresa Corporation — Series B
- SBI Investment (https://capitalatlas.ai/funds/sbi-investment) — Series C
- Yamanashi Chugin Management Consulting (https://capitalatlas.ai/funds/yamanashi-chugin-management-consulting) — Series C
- SUZUKEN CO., LTD. — Series C
- NCB Venture Capital (https://capitalatlas.ai/funds/ncb-venture-capital) — Series C
- Otsuka Pharmaceutical Factory, Inc. — Series C